InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,841.03
(
0.44%
)
US TECH 100
19,636.80
(
0.01%
)
Dow Jones
43,057.74
(
0.74%
)
Brent Oil
74.09
(
-0.51%
)
Bitcoin
67,837.85
(
1.24%
)
Post# of 43403
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DonDonDonDon

Send PM Follow Ignore
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

DonDonDonDon

Re: None

Friday, 04/16/2021 11:27:27 AM

Friday, April 16, 2021 11:27:27 AM

Post# of 43403

Humanigen, Inc.
@humanigen
Last week, our abstract, "Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma,” was presented at the 2021 American Association for Cancer Research Annual Meeting. Use the link below to view the full poster: #AACR2021

https://s27.q4cdn.com/938944131/files/doc_presentations/2021/CT101-Phase-I-safety-and-bioimaging-trial-of-ifabotuzumab-in-patient-with-glioblastoma_final.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up